Founded with a mission to ensure drug quality and safety, RxAll leverages deep learning and hyperspectral IoT technology to authenticate and track pharmaceuticals globally. The company offers an instant testing device, the RxScanner, which allows users to verify the quality of prescribed or supplied drugs in real-time. Additionally, RxAll provides a marketplace platform where buyers can purchase pre-authenticated drugs, and financial solutions to hospitals, pharmacies, and patients to facilitate the acquisition of genuine medications.
RxAll has garnered attention from notable investors and industry experts, contributing to its rapid growth and impact on the pharmaceutical supply chain. The company's innovative approach has significantly enhanced drug safety and accessibility, reducing the prevalence of counterfeit medications. By integrating advanced technology with practical solutions, RxAll is revolutionizing the way drugs are authenticated and distributed, ensuring trust and reliability in the healthcare sector.